ISO 9001:2015 Certified Company
CloseClose the Loader
The cosmetic facility that manufactures or processes a cosmetic product for distribution in the United States on December 29, 2022, must register each facility before July 1, 2024. Cosmetic facilities that first engage in the manufacturing or processing of a cosmetic product for distribution in the United States after December 29, 2022, must register within 60 days of first engaging in such activity or by July 1, 2024, whichever is later.
Biologics have transformed the landscape of cancer treatment, offering targeted and safer therapeutic options. These drugs are engineered to interfere with specific molecules or pathways involved in cancer growth, typically derived from living organisms or their components, such as antibodies, […]
Pharmacovigilance is the science and practice of monitoring, evaluating, and managing the safety of medicinal products. It is essential to ensure that the benefits of a product outweigh its risks, and to identify and prevent any adverse effects or interactions […]
New ZLG Document on Transport Verification Published At the end of August, the German Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (Zentralstelle der Länder für Gesundheitsschutz bei Arzneimitteln und Medizinprodukten, ZLG) […]
How CROs Can Support Pharmacovigilance and Regulatory Compliance? Pharmacovigilance is the process of monitoring, evaluating, and preventing adverse reactions or any other problems related to medicines. It is an essential part of drug development and post-marketing surveillance, as it ensures […]
DCTs are not a fad, but a trend that is transforming clinical research and patient care. By leveraging technology to make trials more accessible
The U.S. Food and Drug Administration (FDA) has given its stamp of approval to Zurzuvae (zuranolone), marking it as the first oral medication specifically designed to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically […]
involving patients directly in pharmacovigilance efforts can be a game-changer. Patient engagement offers unique insights, enhances reporting systems, and fosters a collaborative approach to drug safety.
As healthcare advances, new treatment modalities, personalized medicines, and innovative technologies are reshaping the landscape.
Welcome to the latest edition of our Pharma News and Regulatory News Updates, where we bring you the most significant developments and breakthroughs in the pharmaceutical industry and the latest updates from regulatory agencies worldwide. These highlights from July 1st, […]
